Exopharm Ltd
ASX:EX1
Exopharm Ltd
ASX:EX1
Price:
0.023
AUD
Market Closed
Market Cap:
AU$1.6m
Balance Sheet
Balance Sheet Decomposition
Exopharm Ltd
Exopharm Ltd
Balance Sheet Decomposition is not available for
Exopharm Ltd
Exopharm Ltd
Balance Sheet
Exopharm Ltd
Exopharm Ltd
Currency: AUD
| Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
0
|
0
|
0
|
0
|
4
|
2
|
13
|
5
|
2
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
2
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
4
|
2
|
13
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
3
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
4
|
0
|
0
|
|
| Total Current Assets |
0
|
0
|
0
|
0
|
5
|
4
|
17
|
9
|
5
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
1
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
1
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Total Assets |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
+1 652%
|
7
+21%
|
21
+228%
|
14
-37%
|
6
-57%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
2
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
4
|
2
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
0
N/A
|
0
+280%
|
0
+41 417%
|
0
-11%
|
2
+443%
|
3
+70%
|
5
+86%
|
2
-64%
|
|
| Equity | ||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
8
|
13
|
34
|
34
|
37
|
|
| Retained Earnings |
0
|
0
|
0
|
0
|
2
|
8
|
15
|
26
|
33
|
|
| Total Equity |
0
N/A
|
0
N/A
|
0
-280%
|
0
-857%
|
5
N/A
|
5
-2%
|
19
+276%
|
9
-53%
|
4
-53%
|
|
| Total Liabilities & Equity |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
5
+1 652%
|
7
+21%
|
21
+228%
|
14
-37%
|
6
-57%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
81
|
81
|
81
|
91
|
81
|
95
|
178
|
178
|
439
|
|
Switch to:
Switch to:
See Also
Discover More
